BRIEF published on 03/26/2026 at 16:25, 1 month 15 days ago Sartorius AG Extends René Fáber's Board Appointment Executive Board Sartorius AG Bioprocess Solutions Appointment Extension René Fáber
PRESS RELEASE published on 03/26/2026 at 16:20, 1 month 15 days ago Sartorius AG Supervisory Board extends appointment of board member René Fáber Sartorius AG extends Dr. René Fáber's appointment on the Board until Dec 31, 2031, reinforcing the Bioprocess Solutions Division leadership. Learn more about Sartorius AG's latest decision here Supervisory Board Sartorius AG Appointment Extension René Fáber Bioprocess Solutions Division
BRIEF published on 03/26/2026 at 15:28, 1 month 15 days ago Sartorius AG clôture son assemblée générale annuelle avec des résolutions importantes Résultats Financiers Sartorius Assemblée Générale Annuelle Dividendes Sciences De La Vie
BRIEF published on 03/26/2026 at 15:28, 1 month 15 days ago Sartorius AG Concludes Annual General Meeting with Key Resolutions Financial Results Annual General Meeting Life Sciences Sartorius Dividends
PRESS RELEASE published on 03/26/2026 at 15:23, 1 month 15 days ago Sartorius AG - Resolutions of the Annual General Meeting Sartorius AG's Annual General Meeting results approved dividend of 0.74 euros per preference share and 0.73 euros per ordinary share. Next financial reports in April, July, and October 2026 Annual General Meeting Dividend Financial Reports Biopharmaceutical Sartorius AG
BRIEF published on 03/17/2026 at 07:04, 1 month 24 days ago Sartorius Intensifies Biopharma Strategy with Ambitious Growth Targets Operational Efficiency Growth Targets Bioprocess Solutions Sales Revenue Growth Biopharma Strategy
BRIEF published on 03/17/2026 at 07:04, 1 month 24 days ago Sartorius intensifie sa stratégie biopharmaceutique avec des objectifs de croissance ambitieux Croissance Du Chiffre D'affaires Efficacité Opérationnelle Objectifs De Croissance Solutions De Bioprocédés Stratégie Biopharmaceutique
PRESS RELEASE published on 03/17/2026 at 06:59, 1 month 24 days ago Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets Sartorius sharpens strategy with biopharma focus and sets new mid-term growth targets at Capital Markets Day in Göttingen, Germany Sartorius Strategy Capital Markets Day Growth Targets Biopharma Focus
BRIEF published on 03/16/2026 at 14:09, 1 month 25 days ago Sartorius dévoile une nouvelle plateforme pour améliorer la production de thérapie cellulaire Réduction Des Coûts Efficacité De Production Sartorius Innovation Plateforme De Thérapie Cellulaire Lancement D'Eveo
BRIEF published on 03/16/2026 at 14:09, 1 month 25 days ago Sartorius Unveils New Platform to Enhance Cell Therapy Production Cost Reduction Manufacturing Efficiency Cell Therapy Platform Eveo Launch Sartorius Innovation
Published on 05/09/2026 at 01:30, 1 day 22 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 2 days ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/10/2026 at 16:05, 8 hours 4 minutes ago RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 10 hours 9 minutes ago MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 12 hours 24 minutes ago Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 1 day 5 hours ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 2 days 3 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/07/2026 at 19:15, 3 days 4 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 4 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days 5 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days 5 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 days 5 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
